论文信息 - A randomized, double‐blind, phase III, multicentre study to evaluate the safety and efficacy of BF‐200 ALA (Ameluz®) vs. placebo in the field‐directed treatment of mild‐to‐moderate actinic keratosis with photodynamic therapy (PDT) when using the BF‐RhodoLED® lamp - 字舞流文

A randomized, double‐blind, phase III, multicentre study to evaluate the safety and efficacy of BF‐200 ALA (Ameluz®) vs. placebo in the field‐directed treatment of mild‐to‐moderate actinic keratosis with photodynamic therapy (PDT) when using the BF‐RhodoLED® lamp

C. Berking | U. Reinhold | R. Aschoff | T. Dirschka | R. Szeimies | H. Lübbert | B. Schmitz | W. Philipp-Dormston | R. Ostendorf | S. Hahn | K. Lau | A. Jäger